Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Show Description +

What’s your move when a GA patient on complement inhibition therapy suddenly presents with new fluid? Host David Miller, MD, walks through a real-world conversion from GA to wet AMD and asks panelists Esther Kim, MD, and Ehsan Rahimy, MD, how they spot subtle OCT changes, select a first-line anti-VEGF agent, and coordinate dual therapy.

Posted: 11/10/2025

Keywords:

conversion

•

Neovascular Age-Related Macular Degeneration

•

Geographic Atrophy (GA)

•

fluid

•

Optical coherence tomography (OCT)

•

Anti-VEGF

Up Next

Name: Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History
Uploaded: 2025-11-10T19:02:03+00:00
Description: What’s your move when a GA patient on complement inhibition therapy suddenly presents with new fluid? Host David Miller, MD, walks through a real-world conversion from GA to wet AMD and asks panelists Esther Kim, MD, and Ehsan Rahimy, MD, how they spot subtle OCT changes, select a first-line anti-VEGF agent, and coordinate dual therapy.